Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Patent
1997-07-03
1998-12-22
Kemmerer, Elizabeth C.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
4241921, 514 12, 530350, 530380, A61K 3816, C07K 1446
Patent
active
058515283
ABSTRACT:
The present invention relates to novel chimeric proteins comprising a first polypeptide which inhibits complement activation, linked to a second polypeptide which inhibits complement activation, nucleic acids encoding novel chimeric proteins and methods of reducing inflammation with the administration of the chimeric proteins of the invention.
REFERENCES:
patent: 4774180 (1988-09-01), Toth et al.
patent: 5212071 (1993-05-01), Fearon et al.
patent: 5252216 (1993-10-01), Folena-Wasserman et al.
patent: 5264357 (1993-11-01), Caras et al.
patent: 5627264 (1997-05-01), Fodor et al.
Adams, E.M., et al., "Contribution of the Repeating Domains of Membrane Cofactor Protein (CD46) of the Complement System to Ligand Binding and Cofactor Activity", 1991, J. Immunol., 147:3005-11.
Bailey, P.J., et al., "Immune Complexes and Inflammation: A Study of the Activity of Anti-Inflammatory Drugs In The Reverse Passive Arthus Reaction in the Rat", 1983, Biochem. Pharmacol., 32:475-81.
Caldwell, F.T., et al., "Relationships Between Heat Production, Heat Loss, and Body Temperature for Rats With Burn Injuries Between 26% and 63% of the Body Surface Area", 1993, J. Burn Care & Rehab., 14:420-26.
Chung et al., "Molecular cloning and characterization of the cDNA coding for C4b-binding protein, a regulatory protein of the classical pathway of the human complement system", Biochem. J. 230:133-141 (1985).
Cockett et al., "High Level Expression of Tissue Inhibitor of Metalloproteinases in Chinese Hamster Ovary Cells Using Glutamine Synthetase Gene Amplification", Biotechnology 8:662-667 (1990).
Coyne, K.E., et al., "Mapping of Epitopes, Glycosylation Sites, and Complement Regulatory Domains in Human Decay Accelerating Factor", 1992, J. Immunol., 149:2906-13.
Hosea, S., et al., "Role of Complement Activation in a Model of Adult Respiratory Distress Syndrome", 1980, J. Clin. Invest., 66:375-82.
Hourcade et al., "The Regulators of Complement Activation (RCA) Gene Cluster", Advances in Immunology 45:381-416.
Hsi et al., "Monoclonal Antibody GB24 Recognizes a Trophoblast-Lymphocyte Cross-Reactive Antigen", American Journal of Reproductive Immunology and Microbiology 18:21-27 (1988).
Hussey, R.E., et al., "A Soluble CD4 Protein Selectively Inhibits HIV Replication and Syncytium Formation", 1988, Nature, 331:78-81.
Iwata et al., "Expression of a Hybrid Complement Regulatory Protein, Membrane Cofactor Protein Decay Accelerating Factor on Chinese Hamster Ovary", J. Immunol., 152(7):3436-44 (1994).
Kalli et al., "Mapping of the C3b-binding Site of CRI and Construction of a (CRI).sub.2 -F(AB').sub.2 Chimeric Complement Inhibitor", J. Exp. Med., 174:1451-60 (1991).
Khosla et al., "Expression of Recombinant Proteins in Escherichia Coli Using An Oxygen-Responsive Promoter", Biotechnology, pp. 554-558, Jun., 1990.
Klickstein et al., "Identification of Distinct C3b and C4b Recognition Sites in the Human C3b/C4b Receptor (CR1, CD35) By Deletion Mutagenesis", J. Exp. Med. 168:1699-1717 (1988).
Kojima et al., "Membrane Cofactor Protein (CD46) Protects Cells Predominantly from Alternative Complement Pathway-Mediated C3-Fragment Deposition and Cytolysis", J. Immunol. 151:1519-1527 (1993).
Kotula et al., "Evaluation of Foreign Gene Codon Optimization in Yeast: Expression of a Mouse IG Kappa Chain", Biotechnology 9:1368-1389 (1991).
Krych M., et al., "Analysis of the Functional Domains of Complement Receptor Type 1 (C3b-C4b Receptor; CD35) by Substitution Mutagenesis", 1994, J. Biol. Chem., 269:13273-278.
Krych et al., "Sites within the complement C3b/C4b receptor important for the specificity of ligand binding", Proc. Natl. Acad. Sci. USA 88:4353-4357 (1991).
Lee, et al., "Cloning with Tandem Genes Systems for High Level Gene Expression", 1984, Nucleic Acids Res. 12(17):6797-811.
Leventhal, J.R., et al., "Prolongation of Cardiac Xenograft Survival by Depletion of Complement", 1993, Transplantation, 55:857-66.
Linington, C., et al., "The Role of Complement in the Pathogenesis of Experimental Allergic Encephalomylitis", 1989, Brain, 112:895-911.
Liszewski et al., "Membrane Cofactor Protein (MCP or CD46): Newest Member of the Regulators of Complement Activation Gene Cluster", Annu. Rev. Immunl. 9:431-55 (1991).
Lublin et al., "Molecular Cloning and Chromosomal Localization of Human Membrane Cofactor Protein (MCP)", J. Exp. Med. 168:181-194 (1988).
Masaki et al., "Factor I-Dependent Inactivation of Human Complement C4b of the Classical Pathway by C3b/C4b Receptor (CR1, CD35) and Membrane Cofactor Protein (MCP, CD46)", J. Biochem 111:573-578 (1992).
McNearney et al., "Membrane Cofactor Protein of Complement is Present on Human Fibroblast, Epithelial, and Endothelial Cells", J. Clin. Invest 538-545 (1989).
Medof et al., "Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement", Proc. Natl. Acad. Sci. USA 84:2007-2011 (1987).
Medof et al., "Inhibition of Complement Activation on the Surface of Cells After Incorporation of Decay-Accelerating Factor (DAF) Into Their Membranes", J. Exp. Med. 160:1558-1578 (1984).
Miyagawa et al., "Effect of Transfectant Molecules, MCP, DAF,and MCP/DAF Hybrid, on Complement Mediated Swine Endothelial Cell Lysis", Molec. Immunol., Abstracts of the XV International Complement Workshop, Kyoto, Japan, 30:(Supp 1), (Sep., 1993).
Molina et al., "Analysis of Epstein-Barr Virus-binding Sites on Complement Receptor 2 (CR2/CD21) Using Human-Mouse Chimeras and Peptides", J. Biol. Chem. 266(19):12173-79 (1991).
Moran et al., "Human Recombinant Soluble Decay Accelerating Factor Inhibits Complement Activation In Vitro And In Vivo", J. Immunol. 149:1736-1743 (1992).
Pichler, R., et al., "Tubulointerstitial Disease in Glomerulonephritis: Potential Role of Osteopontin (Uropontin)", 1994, Am. J. Pathology, 144(5):915-23.
Post et al., "Membrane Cofactor Protein of the Complement System: Alternative Splicing of Serine/Threonine/Proline-rich Exons and Cytoplasmic Tails Produces Multiple Isoforms, etc.", J. Exp Med. 174:93-102 (1991).
Ripoche et al., "The Complete Amino Acid Sequence of Human Complement Factor H.", Biochem, J. 249:593-602 (1988).
Sakai et al., "Enhanced Secretion of Human Nerve Growth Factor From Saccharomyces Cervisiae Using an Advanced .beta.-Integration System", Biotechnology 9:1382-1385 (1991).
Scharf et al., "Cloning with PCR", PCR Protocols: A Guide to Methods and Applications, Chapter 11, pp. 84-91, (1990).
Seya et al., "Functional Properties of Membrane Cofactor Protein of Complement", Biochem. J. 264:581-588 (1989).
Seya et al., "Preferential Inactivation of the C5 Convertase of the Alternative Complement Pathway By Factor I and Membrane Cofactor Protein (MCP)", Molecular Immunology 28:1137-1147 (1991).
Seya et al., "Purification and Characterization of a Membrane Protein (gp45-70) That is a Cofactor for Cleavage of C3b and C4b", J. Exp. Med. 163:837-855 (1986).
Sleep et al., "The Secretion of Human Serum Albumin From the Yeast Saccharomyces Cerevisiae Using Five Different Leader Sequences", Biotechnology 8:42-44 (1990).
Steer, M.L., "Pathobiology of Experimental Acute Pancreatitis", 1992, Yale J. Biol. and Med., 65:421-30.
Telen et al., "Molecular Mapping of the Cromer Blood Group Cr.sup.a and Tc.sup.a Epitopes of Decay Accelerating Factor: Toward the Use of Recombinant Antigens in Immunochematology", Blood, 84(9):3205-11, (1994).
Vakeva, A., et al., "Animal Model: Time Course of Complement Activation and Inhibitor Expression after Ischemic Injury of Rat Myocardium", 1994, Am. J. Pathology, 144(6):1357-68.
Weisman, H.F., et al., "Soluble Human Complement Receptor Type 1: In Vivo Inhibitor of Complement Suppressing Post-Ischemic Myocardian Inflammation and Necrosis", 1990, Science, 249:145-51.
Wong et al., "Human GM-CSF: Molecular Cloning of the Complementary DNA and Purification of the Natural and Recombinant Proteins", Science 228:810-815 (1985).
Higgins Paul J.
Ko Jone-Long
Yeh C. Grace
CytoMed, Inc.
Kemmerer Elizabeth C.
Romeo David S.
LandOfFree
Methods of inhibiting complement activation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of inhibiting complement activation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of inhibiting complement activation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2043306